Knowledge graph · Trial
Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
ACTIVE NOT RECRUITING
- Identifier
- CI-TRIAL-00123256
- Entity page
- /trial/NCT02160015 ↗
- Edges
- 7
- Neighbours
- 2 cancers3 drugs
- Drawn
- 5 of 5 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery condition of …CONDITION_OFderived4 of 4 | ||||||||
| ← condition of | Chronic Lymphocytic Leukemia registry condition “Recurrent Chronic Lymphocytic Leukemia” mapped CURATED_BROADER | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| ← condition of | Chronic Lymphocytic Leukemia registry condition “Refractory Chronic Lymphocytic Leukemia” mapped CURATED_BROADER | |||||||